If you could vote on Brexit now which option would you choose?
   

Needle-free injection tech to deliver UK's COVID-19 vaccine


The University of Cambridge has received multi-million-pound funding from the government for a clinical trial of its COVID-19 vaccine. Trial preparations are underway for the vaccine, which will be delivered via an innovative needle-free injection technology developed by US firm PharmaJet. It is hoped that a successful trial will result in the widespread availability of a low-cost vaccine. The vaccine has been developed by DIOSynVax, a spinoff company supported by the University of Cambridge, and uses computer modelling of the virus’ structure to identify the distinct genetic code. The combined artificial intelligence and synthetic biology approach allows for development of a vaccine that is specific to developing antibodies against the SARS-CoV-2 virus.

BusinessCloud - October 28, 2020

View the full story here: https://www.businesscloud.co.uk/news/needle-free-injection-tech-to-deliver-uks-covid-19-vaccine/